slotkoers
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
16.950 KRW | -3,03% | +1,19% | +48,03% |
Vakgebied
Aantal werknemers: 110
Verkoop per activiteit
KRW in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
Pharmaceutical Distribution
64,7
%
| 54 058 | 54,3 % | 63 412 | 64,7 % | +17,30% |
Medicare
29,4
%
| 34 707 | 34,8 % | 28 802 | 29,4 % | -17,01% |
Others
4,5
%
| 4 810 | 4,8 % | 4 413 | 4,5 % | -8,26% |
Construction and Engineering
1,4
%
| 5 886 | 5,9 % | 1 362 | 1,4 % | -76,86% |
Bio Development
0,0
%
| 130 | 0,1 % | 1 | 0,0 % | -99,12% |
Verkoop per regio
KRW in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
South Korea
99,6
%
| 99 484 | 99,9 % | 97 630 | 99,6 % | -1,86% |
Overseas
0,4
%
| 107 | 0,1 % | 361 | 0,4 % | +236,66% |
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Sang-Woo Nam
CEO | Chief Executive Officer | 66 | - |
Yang-Gon Jin
CEO | Chief Executive Officer | 58 | 11-12-15 |
Ki-Hwan Kim
CTO | Chief Tech/Sci/R&D Officer | 54 | - |
Geun-Shik Lee
BRD | Director/Board Member | 51 | - |
Young-Hyun Kim
AUD | Comptroller/Controller/Auditor | 66 | - |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Yang-Gon Jin
CEO | Chief Executive Officer | 58 | 11-12-15 |
Sang-Woo Nam
CEO | Chief Executive Officer | 66 | - |
Yoon-Gi Baek
BRD | Director/Board Member | 61 | - |
In-Geun Jang
BRD | Director/Board Member | 48 | - |
Geun-Shik Lee
BRD | Director/Board Member | 51 | - |
Soo-Ja Choi
BRD | Director/Board Member | 59 | - |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 106 164 461 | 87 881 685 ( 82,78 %) | 69 920 ( 0,0659 %) | 82,78 % |
Participaties
Naam | Aandelen | % | Totale waarde |
---|---|---|---|
HLB CO., LTD. 2.05% | 2 681 798 | 2.05% | 209 563 714 $ |
HLB PHARMACEUTICAL CO., LTD. 13.65% | 4 322 044 | 13.65% | 118 143 894 $ |
HLB SCIENCE INC. 20.55% | 3 365 165 | 20.55% | 10 861 003 $ |
HLB INNOVATION CO.,LTD. 2.93% | 2 074 688 | 2.93% | 9 616 386 $ |
223 638 | 0.30% | 2 245 932 $ |
Bedrijfsgegevens
HLB Life Science Co., Ltd.
3-502, Pangyo Seven Venture Valley 1 15 Pangyo-ro 228beon-gil
13487, Seongnam-si
+
http://www.hlb-ls.comSector
Verkoop per activiteit
Verkoop per regio
Vaira. 1 jan. | Kapi. | |
---|---|---|
+48,03% | 1,32 mld. | |
+17,35% | 71,39 mld. | |
+2,39% | 25,1 mld. | |
+5,38% | 8,59 mld. | |
+6,69% | 8,19 mld. | |
-20,96% | 7,91 mld. | |
+0,49% | 4,54 mld. | |
+17,12% | 4,31 mld. | |
-3,38% | 3,93 mld. | |
-2,61% | 3,86 mld. |
- Beurs
- Aandelen
- Koers A067630
- Onderneming HLB Life Science Co., Ltd.